ライフサイエンスコーパス: lymph

1 on accumulation in the pleural region and in lymph).

2 umors earlier than PyMT mice, with increased lymph and lung metastasis.

3 eting of LPV to HIV reservoirs in mesenteric lymph and MLNs.

4 ly deliver lopinavir (LPV) to the mesenteric lymph and MLNs.

5 on as monotherapy significantly obliterated (lymph)angiogenesis at early time points; however, this t

6 ociated with significant upregulation of pro(lymph)angiogenic VEGF-A, VEGF-C, VEGF-D and infiltration

7 ood, but not those that metastasized through lymph, became dependent on the ferroptosis inhibitor GPX

8 y neuro-immune circuit that is responsive to lymph-borne inflammatory signals.

9 Here we show that melanoma cells in lymph experience less oxidative stress and form more met

10 In addition, during SAH lymph flow is increased but without significant lymphang

11 id cells, yet molecular underpinnings of the lymph gland hemocytes have been less investigated.

12 es between embryonically derived- and larval lymph gland hemocytes.

13 The Drosophila lymph gland, the larval hematopoietic organ comprised of

14 Using Drosophila hematopoietic organ: lymph gland, we demonstrate that Fatty Acid Oxidation (F

15 ure hemocytes have been characterized in the lymph gland: plasmatocytes, lamellocytes, and crystal ce

16 ature reports that the unique composition of lymph may protect melanoma cells from ferroptosis-a form

17 form enables the controlled release of intra-lymph-mobile small-molecular cargo, which can reach vast

18 Bacteria then traffic to the draining lymph node (dLN) where they replicate to large numbers.

19 mphocytic leukemia (CLL) cells cycle between lymph node (LN) and peripheral blood (PB) and display ma

20 The mouse lymph node (LN) can provide a niche to grow metanephric

21 lerance of autoreactive T cells by impairing lymph node (LN) display of peripheral tissue-restricted

22 hocytes begins when tumor antigens reach the lymph node (LN) to stimulate T cells, yet we know little

23 insertion into the most suspicious axillary lymph node (LN) were eligible.

24 subsets derived from peripheral blood (PB), lymph node (LN), and gut tissues of 26 participants afte

25 Little is known regarding lymph node (LN)-homing of immune cells via afferent lymp

26 vanced cervical cancer (LACC) and paraaortic lymph node (PALN) involvement.

27 ility and accuracy of non-radioactive target lymph node (TLN) biopsy and targeted axillary dissection

28 dritic cell IL-27 production in the draining lymph node 12 h after s.c. vaccination directly correlat

29 hort vascular segments displaying peripheral lymph node addressin, and the extravasation of lymphocyt

30 is a delay in neutrophil recruitment to the lymph node and a reduction in swarm formation following

31 nd follicular helper T cells in the draining lymph node and Ag-specific Th1 and Th17 cells in the spl

32 Thus, lymph node and distant metastases develop through fundam

33 patients and associated with tumor staging, lymph node and distant metastasis.

34 letion of migDC2 reduces the amount of Ag in lymph node and the development of IFNgamma, IL-4 and IL-

35 ively with tumor grading and the presence of lymph node as well as distant metastases and is specific

36 gen-induced immune responses in the draining lymph node at lower doses and reduced administration fre

37 Sentinel lymph node biopsy is a promising procedure in patients w

38 mmunohistochemical analyses of tissue from a lymph node biopsy; the tissue morphology and antigen exp

39 Mediastinal sequelae included lymph node calcification (74%), fibrosing mediastinitis

40 The small population of neutrophils in the lymph node can act as reconnaissance cells to recruit ad

41 e thus able to alter the subtypes of drugged lymph node cells to improve immunotherapeutic effects.

42 Normal canine pancreas and lymph node control tissues were compared with primary IN

43 k, delivering cargo to specific cells in the lymph node cortex and paracortex is difficult.

44 , lamina propria macrophages, and mesenteric lymph node dendritic cells were examined.

45 This was followed by extended pelvic lymph node dissection (ePLND).

46 y tumor and postchemotherapy retroperitoneal lymph node dissection (PC-RPLND) specimen and assess imp

47 ndings with radical prostatectomy and pelvic lymph node dissection (PLND) histopathology findings.

48 e relapse rate after primary retroperitoneal lymph node dissection (RPLND) for patients with patholog

49 ific antigen (PSA) persistence after salvage lymph node dissection (SLND) and pre-procedure and post-

50 sed use of radical prostatectomy with pelvic lymph node dissection for primary management of high-ris

51 ed surgery and discusses its implications in lymph node dissection in primary and recurrent prostate

52 A total of 1,019 patients with complete lymph node dissection of American Joint Committee on Can

53 Twenty HNSCC patients scheduled for lymph node dissection underwent DCE-MRI, dynamic PET, an

54 onchovascular thickening, satellite nodules, lymph node enlargement, and pleural effusion).

55 that at steady state, neutrophils enter the lymph node entirely via L-selectin and actively exit via

56 vated DCs acquiring features compatible with lymph node homing and antigen presentation, but unexpect

57 of neutrophils at steady state fortifies the lymph node in case of an infection disseminating through

58 PD-L1 expressing dendritic cells within the lymph node in regulation of anti-tumor immune responses.

59 ing criteria: estrogen receptor (ER) status, lymph node invasion, recurrence free survival.

60 tion of smaller cancers with less associated lymph node involvement and a reduction in the rate of in

61 and compare imaging results with the risk of lymph node involvement based on the Roach formula.

62 Microscopic lymph node involvement in patients with PTC is common, b

63 The risk of lymph node involvement was calculated using the Roach fo

64 f androgen deprivation therapy (ADT) and had lymph node irradiation.

65 Our results demonstrate the intrinsic lymph node LXA(4) pathway as a significant checkpoint in

66 common iliac (6/16, 38%) and internal iliac lymph node metastases (6/16, 38%).

67 Undetected lymph node metastases (LNMs) underwent immunohistochemic

68 tumor samples, covering the primary tumors, lymph node metastases (LNMs), and liver metastases from

69 ) have a distinct MRI appearance compared to lymph node metastases (mrLNMs).

70 Polyclonal seeding was common in untreated lymph node metastases (n = 17 out of 29, 59%) and distan

71 reast is correlated with absence of axillary lymph node metastases at final pathology (ypN0) in patie

72 ntification of 4 previously unknown lung and lymph node metastases in 2 patients.

73 patients with recurrences to develop lung or lymph node metastases is eightfold (p = 0.056).

74 Lymph node metastases that occur frequently provide site

75 The presence of lymph node metastases was determined by an experienced r

76 Results: Lymph node metastases were present in 18 patients (31.0%

77 Lymph node metastases were present in the pelvis in 42%

78 Lymph node metastases, in contrast, display high levels

79 recurrences have a higher risk for lung and lymph node metastases.

80 h edition; AJCC-7), stage IIIA (at least one lymph node metastasis > 1 mm), IIIB, or IIIC (without in

81 llow-up (P = 0.05), and longer time to first lymph node metastasis (P = 0.04).

82 expression of Zic1 was correlated with more lymph node metastasis and poor outcome of GC patients.

83 s was positively associated with tumor size, lymph node metastasis, and FIGO stage.

84 nt, including growth of invasive cancers and lymph node metastasis.

85 ecific alarmins induced their proliferation, lymph node migration, and blood dissemination, thus syst

86 l-length viral DNA from peripheral blood and lymph node mononuclear cells (PBMC and LNMC) during ART

87 Median age was 49 years, 55.9% were lymph node negative, 73.9% had a basal phenotype, and 67

88 ability to recruit additional neutrophils by lymph node neutrophils is initiated by LTB4.

89 entering or distributing within the draining lymph node of ectromelia virus (ECTV)-infected mice or a

90 -mediated premetastatic niche created in the lymph node of TRL-positive patients misleads 18F-FDG-PET

91 For patients with involved lymph nodes, lymph node ratio was an independent predictor of progres

92 umors transport antigens and share them with lymph node resident DCs through cross-presentation.

93 atics and the size-restrictive nature of the lymph node reticular network, delivering cargo to specif

94 timulation assays in colon, tonsil, and oral lymph node samples.

95 Regional lymph node scanning was routinely done by 14/23 (61%) an

96 three settings: in vitro wound healing, live lymph node sections and a live tumor microenvironment.

97 nces in MRI parameters and relationship with lymph node stage.

98 treatment TRL misleads 18F-FDG-PET/CT during lymph node staging in gynecological malignancies.

99 should include D2 lymphadenectomy (including lymph node stations in the perigastric mesentery and alo

100 ter RARP (P = 0.004) and positive pathologic lymph node status (P = 0.006) were independent predictor

101 fication factors were breast cancer therapy, lymph node status, hormone receptor and HER2 status, age

102 Lymph node stromal cells (LNSC) are essential for provid

103 be programmed, allowing access to different lymph node structures and therefore specific lymphocyte

104 ing metastasis and performing imaging-guided lymph node surgery is challenging.

105 each vastly more immune cells throughout the lymph node than either the particles or free compounds a

106 ne sequencing; lamina propria and mesenteric lymph node tissues were analyzed by RNA sequencing and f

107 justed for age, stage, and histology, pelvic lymph node TLG, PALN TLG, and PALN SUV(max) were signifi

108 gic surgical options, including vascularized lymph node transplant (VLNT) and lymphovenous bypass (LV

109 mple Ags in the periphery and migrate to the lymph node where they activate T cells.

110 ling, and increased seeding to the liver and lymph node work as interconnected pathways, leading to t

111 rbidity, mortality, radicality of resection, lymph node yield and 3-year conditional survival did not

112 , downstages patients, and decreases overall lymph node yields (LNY) compared to initial surgical res

113 compared with control in patients with bone, lymph node, and chest wall/breast/skin metastases at bas

114 ced/MBC for patients with bone, liver, lung, lymph node, and chest wall/breast/skin metastases.

115 ition specifically within the tumor-draining lymph node, identifying a potential role for PD-L1 expre

116 h peripheral blood and the draining axillary lymph node, indicating significant BCG vaccine-induced i

117 In lymph node-positive, triple-negative breast cancer (TNBC

118 ciated with a 10% risk of missing a positive lymph node.

119 eactive T cells in the spleen and pancreatic lymph node.

120 mulated equally in the recipient mediastinal lymph node.

121 re may function as a kidney-specific type of lymph node.

122 the event of bacterial dissemination to the lymph node.

123 80 cases, SLN biopsy resulted in a positive lymph node.

124 edema, areola-nipple complex retraction, and lymph-node involvement were associated with recurrence a

125 a more advanced primary tumor and SW620 from lymph-node metastasis.

126 eased by an average of 36%, whereas sentinel lymph-node procedures decreased by 45%, lung scans by 56

127 Lymph-node tissue from axilla was positive for the long-

128 their partial depletion in the gut (25%) and lymph nodes (>50%).

129 g (33 patients), peritoneum (32), and portal lymph nodes (14).

130 gher sensitivity than CT or (18)F-FDG PET in lymph nodes (92.4% vs. 69.7% and 89.4%, respectively) an

131 Axillary lymph nodes (ALNs) are the regions where BC cells first

132 ules and immune cells from CSF into cervical lymph nodes (CLNs).

133 as a decreased number of LC in skin-draining lymph nodes (LN).

134 io of positive lymph nodes to total assessed lymph nodes (LNR) is an indicator of cancer burden in es

135 Lymph nodes (LNs) are strategically positioned at dedica

136 The presence of metastasis in local lymph nodes (LNs) is a key factor influencing choice of

137 NA levels, and in inducible SIV reservoir in lymph nodes (LNs) of morphine administered RMs.

138 nd the three-dimensional context of reactive lymph nodes (LNs).

139 nses at peripheral sites and within draining lymph nodes (LNs).

140 DCs of mesenteric lymph nodes (MLN) and joint regional lymph nodes (RLN) w

141 creased in the interfollicular space of iMCD lymph nodes (N = 26) compared with control lymph nodes b

142 86 and .006, respectively), and the draining lymph nodes (P = .02).

143 ntly invasive (P < .001), had fewer positive lymph nodes (P = .04) and distant metastases (P = .01),

144 DSC MRI were associated with local malignant lymph nodes (pN status).

145 enteric lymph nodes (MLN) and joint regional lymph nodes (RLN) were analyzed in TNFRp55(-/-) and wild

146 ing in reduced LC migration to skin-draining lymph nodes (sdLNs) and defective skin tolerance inducti

147 5% in the submucosa (ypT1b) and 6.4% only in lymph nodes (ypT0N+).

148 r patients with T1-2 tumors and 1-3 positive lymph nodes after undergoing PMRT.

149 DWI signal less than that in endometrium or lymph nodes allowed readers to confidently diagnose as b

150 e DC population in the heart and mediastinal lymph nodes and analyzed long-term cardiac immunopatholo

151 ored the Th17 and Treg content in mesenteric lymph nodes and aorta.

152 itic cells migrating to mediastinal draining lymph nodes and bearing migratory and immunoregulatory m

153 CD4(+) T cell counts in both the mesenteric lymph nodes and colon.

154 mmed-death-ligand-1) in spinal cord-draining lymph nodes and decreases the number of T helper 17 cell

155 a L-selectin and high endothelial venules in lymph nodes and demonstrates how the presence of neutrop

156 o, these memory cells preferentially home to lymph nodes and display rapid proliferation and effector

157 nfection site, transiting through sequential lymph nodes and efferent lymphatic vessels to enter the

158 17 cells rapidly proliferate within neonatal lymph nodes and gut, where, upon entry, they upregulate

159 In the pelvis, (18)F-DCFPyL depicted more lymph nodes and improved positive predictive value and s

160 uces Treg and Breg elevation in the lal(-/-) lymph nodes and improves human cancer cell rejection.

161 ells with reduced effector capacity populate lymph nodes and intestines and exhibit tissue-resident s

162 e aspiration to serially sample the draining lymph nodes and investigate the dynamics and specificity

163 rofile transcriptomes of BEC from peripheral lymph nodes and map phenotypes to the vasculature.

164 In contrast to the lymph nodes and mucosal lymphoid tissues with well-defin

165 g chemokine-mediated T cell trafficking into lymph nodes and PDK1-dependent soluble Ag uptake, costim

166 zed lymphoid tissues, such as the mesenteric lymph nodes and Peyer's patches, as well as in the lamin

167 nd in the MHC-II peptidome of the pancreatic lymph nodes and spleen.

168 g etiology, we examined post mortem thoracic lymph nodes and spleens in acute SARS-CoV-2 infection an

169 ables in histopathologic studies of positive lymph nodes and surgical specimens: size, lymphovascular

170 s drainage can occur directly to mediastinal lymph nodes and there is no interlobar lymphatic flow.

171 omposition, structure, and gene signature as lymph nodes and therefore may function as a kidney-speci

172 mechanisms regulating lymphocyte homing into lymph nodes are only partly understood.

173 Prominent uptake was seen in multiple normal lymph nodes as early as 2 h after injection, peaking by

174 ) of macrophages isolated from submandibular lymph nodes as observed by flow cytometry.

175 ecipient, Cosmc-null B cells fail to home to lymph nodes as well as non-lymphoid organs.

176 identified transcriptional signatures in the lymph nodes associated with differences in T cell popula

177 ensemble of three-dimensional CNNs detected lymph nodes at a performance nearly comparable to differ

178 nts with T1-2 breast cancer and 1-3 positive lymph nodes at our institution.

179 ZIKV RNA was detected in lymph nodes but not the ovaries, uterus, cervix, or vagi

180 D lymph nodes (N = 26) compared with control lymph nodes by immunohistochemistry (IHC) for pS6, p4EBP

181 specific CD8(+) T cells in the skin draining lymph nodes compared to a conventional intradermal injec

182 caused selective downregulation of LXA(4) in lymph nodes draining the site of immunization, while at

183 Two thirds scanned regional lymph nodes during the follow-up.

184 ot simply because they transport antigens to lymph nodes for processing by cDC2, as selective deletio

185 potential and requires T cell migration from lymph nodes for therapeutic efficacy.

186 were immunological changes in granulomas and lymph nodes from anti-IL-10-treated animals.

187 For lymph nodes from the external institution, the algorithm

188 Tregs from cervical lymph nodes had reduced Foxp3 expression (> 25% MFI loss

189 admission, oncologic outcomes (R0-resection, lymph nodes harvested), and operative times.

190 Therapeutic delivery selectively to lymph nodes has the potential to address a variety of un

191 Tracer was found in regional lymph nodes in 100% of patients in 21 of 27 articles and

192 sfer into and presentation in tumor-draining lymph nodes induce activation of tumor-specific T-lympho

193 lly partition the primary tumor and involved lymph nodes into subregions (i.e., habitats) based on (1

194 revealed increased SIV RNA expression in the lymph nodes of macaques and robust induction of HIV in a

195 MC-derived IL-13 acted on DCs from draining lymph nodes of OVA-sensitized skin to selectively suppre

196 ucing CCR6(+)T cells were highly abundant in lymph nodes of SLE patients, and colocalized with B cell

197 ritic cells (DCs) purified from the draining lymph nodes of tape-stripped and ovalbumin (OVA)-sensiti

198 uced the concentration of IL-12 and IL-17 in lymph nodes of treated and contralateral tumors suggesti

199 ve MRI criteria for malignancy were enlarged lymph nodes or peritoneal implants, high DWI signal grea

200 ever, its role in patients with 1-3 positive lymph nodes remains unclear.

201 ene profiles of whole kidney, renal TLS, and lymph nodes revealed a similar gene signature of TLS and

202 Tonsils are the lymph nodes serving the upper respiratory tract, acting

203 (18)F-DCFPyL depicted more pelvic lymph nodes than did MRI (128 vs 23 nodes).

204 We hypothesized that the ratio of positive lymph nodes to total assessed lymph nodes (LNR) is an in

205 eleration of naive T cell recruitment to the lymph nodes upon inflammation.

206 d subsequently migrate toward the mesenteric lymph nodes via the mesenteric lymphatic capillaries.

207 The median number of examined lymph nodes was 21 after McKeown TMIE and 25 after Ivor

208 The median number of involved lymph nodes was 3 (range, 1-37 nodes), and the median si

209 Removing 25 to 30 lymph nodes was associated with a 10% risk of missing a

210 A lower number of excised lymph nodes was independently associated with worse OS a

211 (P = 0.089), whereas involvement of thoracic lymph nodes was significantly associated with an adverse

212 Histologically positive lymph nodes were associated with a greater percentage of

213 Lymph nodes were detected in 23 patients and bone metast

214 Lymph nodes were segmented and annotated as ENE-positive

215 ), PS, and K(trans) values of the metastatic lymph nodes were significantly lower (p = <0.05) than th

216 Pattern analysis showed that pelvic lymph nodes were the most common site of recurrence, and

217 sponse in primary tumors and in the axillary lymph nodes with metastasis (ALN(+)) in breast cancer (B

218 xamination of the primary tumor and draining lymph nodes) require the infrastructure and expertise of

219 Tumor grading, number of positive lymph nodes, a context of intraductal papillary mucinous

220 49.6% of patients (22 local recurrences, 63 lymph nodes, and 31 distant metastases).

221 tified: 37 prostate bed foci, 208 lesions in lymph nodes, and 42 in distant sites in bones or organs,

222 rior taxane-based therapy, involved axillary lymph nodes, and centrally determined phenotype (basal v

223 est contrast was achieved in primary tumors, lymph nodes, and distant metastases at 1 h after injecti

224 dometriotic lesion, enlarged retroperitoneal lymph nodes, and immune cells infiltration, indicating t

225 ed dendritic cell numbers in the mediastinal lymph nodes, and increased T-helper type 2 (T(H) 2)-cell

226 live T cells from thymus, spleen, pancreatic lymph nodes, and islets before and after diabetes.

227 Biodistribution in normal organs, lymph nodes, and lesions was evaluated.

228 ere determined for the primary tumor, pelvic lymph nodes, and PALNs.

229 We conducted cytokine profiling in tumor, lymph nodes, and serum of animals within the first 24 h

230 n the retina, cervical lymph nodes, inguinal lymph nodes, and spleen.

231 within the prostate fossa, local and distant lymph nodes, bones, or visceral organs was recorded.

232 cell TGF-beta signalling in tumour-draining lymph nodes, causing reorganization of tumour vasculatur

233 mphatic vessels connect the primary tumor to lymph nodes, facilitating tumor entry into lymph nodes,

234 mmended for patients with 4 or more positive lymph nodes, however, its role in patients with 1-3 posi

235 cells and IFN-gamma production in mesenteric lymph nodes, increased expression of Ido1 in the cecum,

236 lper 17 (Th17) cells in the retina, cervical lymph nodes, inguinal lymph nodes, and spleen.

237 For patients with involved lymph nodes, lymph node ratio was an independent predict

238 as performed on transcriptomes isolated from lymph nodes, macrodissected TLS from kidneys, and total

239 nes, nanovaccines provide improved access to lymph nodes, optimal packing and presentation of antigen

240 s with PTLD in the Waldeyer's ring, cervical lymph nodes, or small bowel with either nondestructive o

241 systems, including the lungs, spleen, liver, lymph nodes, pancreas and extrahepatic bile duct with po

242 with significantly lower rates of pathologic lymph nodes, perineural invasion, and venous invasion.

243 Ga-PSMA-11 for ganglia, bone, and unspecific lymph nodes, respectively).

244 compared with primary INS and INS-metastatic lymph nodes, revealing more than 3,000 genes differentia

245 ls and their recruitment to the CNS-draining lymph nodes, sparing their liver-draining counterparts.

246 ssues known to be viral reservoirs including lymph nodes, spleen, bone marrow, and brain among others

247 ion of dendritic cells in the tumor-draining lymph nodes, subsequently initiating T cell-mediated imm

248 o lymph nodes, facilitating tumor entry into lymph nodes, systemic circulation, and metastasis.

249 es analysed in humanized mice, including the lymph nodes, thymus, bone marrow, liver and lung.

250 terization of immune cells in the mesenteric lymph nodes, to delineate colonic immune niches at stead

251 rane-bound protein in HNSCC cells of invaded lymph nodes, vascular endothelial growth factor-A (VEGF-

252 Within lymph nodes, we observed augmented GC B cell responses a

253 ce germinal centre reactions in the draining lymph nodes, where diversification and maturation of rec

254 lay peripheral tissue-restricted antigens in lymph nodes, which impaired their capacity to purge and

255 s' age at diagnosis or information regarding lymph nodes, which were employed to build various novel

256 r patients with T1-2 tumors and 1-3 positive lymph nodes, who underwent mastectomy from 2004 to 2015.

257 cy, and it is useful in identifying sentinel lymph nodes.

258 (hypoxia) such as in the liver, spleen, and lymph nodes.

259 F(+) CD11b(hi) NK cells expanded in draining lymph nodes.

260 (local or non-local) or spread to airways or lymph nodes.

261 equency in islet infiltration and pancreatic lymph nodes.

262 to increase naive T cell trafficking to the lymph nodes.

263 ing blood, bone marrow, spleen, and draining lymph nodes.

264 ood, spleen, bronchoalveolar lavage and lung lymph nodes.

265 opulation which is expanded in the blood and lymph nodes.

266 s of treatment response, is approximately 25 lymph nodes.

267 btype interacting with DCs in mouse draining lymph nodes.

268 tients with negative (pN0) or positive (pN1) lymph nodes.

269 ion in the lung, independent of the draining lymph nodes.

270 bound form of the CD40L by CD4(+) T cells in lymph nodes.

271 ablished, TIDC did not migrate into sentinel lymph nodes.

272 rry the bacteria through successive draining lymph nodes.

273 eptors (R) in vitro and in inflamed draining lymph nodes.

274 mented T cell infiltration in tumor-draining lymph nodes.

275 revealed a similar gene signature of TLS and lymph nodes.

276 essed between primary INS and INS-metastatic lymph nodes.

277 rgery, including identification of cancer in lymph nodes.

278 ction in CD4(+) T cell numbers in mesenteric lymph nodes.

279 ofiled for immune responses in the blood and lymph nodes.

280 n the levels of NK cells in tonsils and oral lymph nodes.

281 asia, and lymphocyte depletion of spleen and lymph nodes.

282 tic cells and T-cell priming in the draining lymph nodes.

283 tion of both Treg and Th17 cells in cervical lymph nodes.

284 ficient to activate the angiogenic switch in lymph nodes.

285 mous cell carcinoma (SCC), and more positive lymph nodes.

286 in interstitial fluid into the deep-cervical lymph nodes.

287 uces Treg and Breg elevation in the lal(-/-) lymph nodes.

288 lung, liver, and brain, but not for bone or lymph nodes.

289 ed the highest-contrast PET images of target lymph nodes.

290 mproved immune cell infiltration in draining lymph nodes.

291 ophobic odorant molecules across the aqueous lymph present in antennal sensilla to receptors present

292 eby lung lymphatic network expansion reduces lymph stasis and increases clearance of fluid and cells,

293 noma cells per microlitre in tumour-draining lymph than in tumour-draining blood.

294 stems from changes in a specialized receptor lymph that bathes the auditory receptors, revealing stri

295 reased numbers of regulatory T-like cells in lymph tissues in association with systemic tolerance.

296 valve defects are one of the major causes of lymph transport dysfunction.

297 tch may play an important role in regulating lymph transport, and demonstrate that changes in axial s

298 contractile activity is necessary for proper lymph transport.

299 The maximum levels of LPV in mesenteric lymph were 1.6- and 16.9-fold higher than protein bindin

300 ells in human and non-human primate efferent lymph were T cells.